From clinical trials to the medical office
Kaiser Permanente’s oncology clinical trials give our members access to new cancer therapies before they’re approved by the Food and Drug Administration (FDA), making it possible for patients like Margarita to get innovative medications and treatments before they’re commercially available. These trials are a key driver of medical advances, leading to new, effective ways to help prevent, detect, and treat diseases.
Other advances and initiatives from the Kaiser Permanente Oncology Clinical Trials program include:
- a new therapy for lung cancer patients that trains their immune systems to attack cancer cells directly
- frequent text message reminders to help women with breast cancer keep up with their daily medication regimen
Ongoing trials and research across the organization
At Kaiser Permanente, our team of doctors, nurses, and specialists reviews and selects clinical trials they determine need further study — underscoring our efforts to cultivate continuous improvement in everything we do. Clinical trials are just one example of our organization-wide commitment to research.
Read more about our oncology clinical trials program.
Learn more about research at Kaiser Permanente.